Penn Davis McFarland’s AbbVie ABBV Stock Holding History

Penn Davis McFarland’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.71M	Buy	30,630 +166	+0.5%	+$35.7K	0.69%	31
2026 Q1	$6.63M	Hold	30,464	–	–	0.65%	31
2025 Q4	$6.96M	Sell	30,464 -50	-0.2%	-$11.4K	0.67%	29
2025 Q3	$7.07M	Hold	30,514	–	–	0.73%	28
2025 Q2	$5.66M	Sell	30,514 -50	-0.2%	-$9.29K	0.64%	30
2025 Q1	$6.4M	Sell	30,564 -80	-0.3%	-$15.6K	0.76%	29
2024 Q4	$5.45M	Sell	30,644 -298	-1%	-$54.8K	0.59%	30
2024 Q3	$6.11M	Buy	+30,942	New	+$5.77M	0.69%	32

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Penn Davis McFarland's ABBV Position: Q2 2026 in Review

Penn Davis McFarland increased its AbbVie (ABBV) stake by 0.54% in Q2 2026, buying an estimated $35.7K and bringing the position to 30,630 shares worth $7.71M. The position accounts for 0.69% of the portfolio, ranked #31.

Penn Davis McFarland first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 1,568 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Penn Davis McFarland held 30,630 shares of AbbVie worth $7.71M as of Q2 2026.
Penn Davis McFarland bought 166 AbbVie shares in Q2 2026, an estimated $35.7K.
AbbVie made up 0.69% of Penn Davis McFarland's portfolio in Q2 2026, its #31 holding.
Penn Davis McFarland first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
1,568 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.